Cargando…

The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model

PURPOSE: The aim of this study was to investigate and compare the effects of udenafil and mannitol in an experimental renal ischemia-reperfusion (I/R) injury model. MATERIALS AND METHODS: A total of 64 female Wister Albino rats were used. Right nephrectomy was performed in all groups. In the control...

Descripción completa

Detalles Bibliográficos
Autores principales: Özlülerden, Yusuf, Toktaş, Cihan, Aybek, Hülya, Küçükatay, Vural, Şen Türk, Nilay, Zumrutbas, Ali Ersin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Urological Association 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494354/
https://www.ncbi.nlm.nih.gov/pubmed/28681040
http://dx.doi.org/10.4111/icu.2017.58.4.289
_version_ 1783247664726409216
author Özlülerden, Yusuf
Toktaş, Cihan
Aybek, Hülya
Küçükatay, Vural
Şen Türk, Nilay
Zumrutbas, Ali Ersin
author_facet Özlülerden, Yusuf
Toktaş, Cihan
Aybek, Hülya
Küçükatay, Vural
Şen Türk, Nilay
Zumrutbas, Ali Ersin
author_sort Özlülerden, Yusuf
collection PubMed
description PURPOSE: The aim of this study was to investigate and compare the effects of udenafil and mannitol in an experimental renal ischemia-reperfusion (I/R) injury model. MATERIALS AND METHODS: A total of 64 female Wister Albino rats were used. Right nephrectomy was performed in all groups. In the control group; I/R injury was not performed. In the I/R group; left renal pedicle was clamped for 45 minutes and then underwent 60 minutes and 24 hours of reperfusion. In the mannitol group; 1 mL 20% mannitol was given intravenously 15 minutes before clamping. In the udenafil group; 10-mg/kg udenafil was given orally 1 hour before clamping. Creatinine (Cr), blood urea nitrogen (BUN), Cr clearance, malondialdehyde, neutrophil gelatinase associated lipocalin (NGAL), histological examination and DNA damage (Comet Assay method) levels were compared in tissue, serum and urine samples. RESULTS: Udenafil had a better protective effect than mannitol according to biochemical parameters (Cr, BUN, Cr clearance, and NGAL levels) and histopathological findings when compared with the I/R group. In the Comet sampling analysis no significant difference was detected. CONCLUSIONS: Udenafil has a better renoprotective effect than mannitol against I/R injury and this effect supports more functional improvements. Further clinical trials are needed to demonstrate those effects and clinical utility of udenafil for that purpose in humans.
format Online
Article
Text
id pubmed-5494354
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Korean Urological Association
record_format MEDLINE/PubMed
spelling pubmed-54943542017-07-05 The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model Özlülerden, Yusuf Toktaş, Cihan Aybek, Hülya Küçükatay, Vural Şen Türk, Nilay Zumrutbas, Ali Ersin Investig Clin Urol Original Article PURPOSE: The aim of this study was to investigate and compare the effects of udenafil and mannitol in an experimental renal ischemia-reperfusion (I/R) injury model. MATERIALS AND METHODS: A total of 64 female Wister Albino rats were used. Right nephrectomy was performed in all groups. In the control group; I/R injury was not performed. In the I/R group; left renal pedicle was clamped for 45 minutes and then underwent 60 minutes and 24 hours of reperfusion. In the mannitol group; 1 mL 20% mannitol was given intravenously 15 minutes before clamping. In the udenafil group; 10-mg/kg udenafil was given orally 1 hour before clamping. Creatinine (Cr), blood urea nitrogen (BUN), Cr clearance, malondialdehyde, neutrophil gelatinase associated lipocalin (NGAL), histological examination and DNA damage (Comet Assay method) levels were compared in tissue, serum and urine samples. RESULTS: Udenafil had a better protective effect than mannitol according to biochemical parameters (Cr, BUN, Cr clearance, and NGAL levels) and histopathological findings when compared with the I/R group. In the Comet sampling analysis no significant difference was detected. CONCLUSIONS: Udenafil has a better renoprotective effect than mannitol against I/R injury and this effect supports more functional improvements. Further clinical trials are needed to demonstrate those effects and clinical utility of udenafil for that purpose in humans. The Korean Urological Association 2017-07 2017-06-27 /pmc/articles/PMC5494354/ /pubmed/28681040 http://dx.doi.org/10.4111/icu.2017.58.4.289 Text en © The Korean Urological Association, 2017 http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Özlülerden, Yusuf
Toktaş, Cihan
Aybek, Hülya
Küçükatay, Vural
Şen Türk, Nilay
Zumrutbas, Ali Ersin
The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
title The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
title_full The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
title_fullStr The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
title_full_unstemmed The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
title_short The renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
title_sort renoprotective effects of mannitol and udenafil in renal ischemia-reperfusion injury model
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494354/
https://www.ncbi.nlm.nih.gov/pubmed/28681040
http://dx.doi.org/10.4111/icu.2017.58.4.289
work_keys_str_mv AT ozlulerdenyusuf therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT toktascihan therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT aybekhulya therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT kucukatayvural therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT senturknilay therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT zumrutbasaliersin therenoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT ozlulerdenyusuf renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT toktascihan renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT aybekhulya renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT kucukatayvural renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT senturknilay renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel
AT zumrutbasaliersin renoprotectiveeffectsofmannitolandudenafilinrenalischemiareperfusioninjurymodel